Omega Therapeutics, Inc. announced the appointment of Yan Moore, M.D., as Chief Medical Officer. Dr. Moore most recently served as Senior Vice President, Head of Oncology Therapeutic Area at Ipsen Pharmaceuticals.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.145 USD | -0.46% | -13.51% | -28.74% |
May. 06 | Omega Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 16 | Omega Therapeutics CFO Joshua Reed to Depart | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.74% | 118M | |
+22.56% | 46.71B | |
-1.51% | 41.52B | |
+48.83% | 41.8B | |
-3.42% | 29.55B | |
+10.13% | 25.78B | |
-20.44% | 19.26B | |
+26.45% | 11.98B | |
-0.14% | 12.14B | |
-0.47% | 12.08B |
- Stock Market
- Equities
- OMGA Stock
- News Omega Therapeutics, Inc.
- Omega Therapeutics Announces Appointment of Yan Moore as Chief Medical Officer